In India’s Cancer Crisis: 3 out of five patients die, ICMR warns

The primary medical panel of India has revealed that three out of five people die after cancer diagnosis. The recent report of the Indian Medical Research Council in India (ICMR), published in India’s Lancet, has found that the occurrence of cancer has increased more in women than in men, over the last decade, and this trend continues to grow over the last two decades, and the researchers wrote global cancer monitoring (Globocan) 2022.

“About three in five in five people in India will die after the cancer diagnosis, such as the prevalence of Globocan 2022 (1,413,316) in mortality (916,827),” the researchers stated in the Lancet study.

An ICMR study using Globocan data showed that India is third in cancer in the world of cancer after the United States and China and mortality after China. Although breast cancer affects women more, lung cancer causes the most deaths in both sexes.

Older adults have a much greater risk than younger people, and as the younger India population is aging in the coming decades, cancer is expected to rise, researchers wrote. In the analysis, it was stated that in India, persons of childhood and reproductive age have the lowest risk of developing and dying of cancer compared to middle-aged and geriatric age groups.

“This information shows that in the coming years India may face a huge cancer. Alarmingly, cancer deaths rise faster among women (1.2-4.4 per year) than men (1.2-2.4 per year), “The authors wrote. 64.7-109.6 In 2022-2050.

A comprehensive study examined 36 cancer types according to sex, and in four separate ages, Age in India 3. They emphasize the urgent need to create focused interventions and strategies to combat the growing cancer of India.

Source https://www.indiatoday.in/health/story/india-cancer-crisis-three-out-of-five-patients-die-top-medical-body-icmr-warns-women-at-high-risk-2686308-2025-02-27

https://timesofindia.indiatimes.com/india/three-out-of-five-in-india-succumb-to-cancer-after-diagnosis-icmr/articleshow/118567092.cms

Tags:

Comments are closed

Latest Comments

No comments to show.
Scroll to Top